ImmunityBio, Serm Institute of India enter BCG supply arrangement

ImmunityBio has signed an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses produced, to supply ImmunityBio with Bacillus Calmette-Guerin, or BCGc. The agreement covers the manufacturing of standard BCG that is currently approved for use outside the U.S., as well as a next-generation recombinant BCG undergoing testing, intended for use in combination with ImmunityBio’s ANKTIVA for currently approved and potential future indications, subject to regulatory approvals.